CONMED Shares Outstanding 2010-2023 | CNMD

CONMED shares outstanding from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
CONMED Annual Shares Outstanding
(Millions of Shares)
2023 32
2022 30
2021 32
2020 29
2019 29
2018 29
2017 28
2016 28
2015 28
2014 28
2013 28
2012 29
2011 29
2010 29
2009 29
CONMED Quarterly Shares Outstanding
(Millions of Shares)
2023-12-31 32
2023-09-30 32
2023-06-30 32
2023-03-31 31
2022-12-31 30
2022-09-30 31
2022-06-30 30
2022-03-31 35
2021-12-31 32
2021-09-30 32
2021-06-30 32
2021-03-31 31
2020-12-31 29
2020-09-30 29
2020-06-30 29
2020-03-31 30
2019-12-31 29
2019-09-30 30
2019-06-30 29
2019-03-31 29
2018-12-31 29
2018-09-30 29
2018-06-30 29
2018-03-31 29
2017-12-31 28
2017-09-30 28
2017-06-30 28
2017-03-31 28
2016-12-31 28
2016-09-30 28
2016-06-30 28
2016-03-31 28
2015-12-31 28
2015-09-30 28
2015-06-30 28
2015-03-31 28
2014-12-31 28
2014-09-30 28
2014-06-30 28
2014-03-31 28
2013-12-31 28
2013-09-30 28
2013-06-30 28
2013-03-31 29
2012-12-31 29
2012-09-30 29
2012-06-30 29
2012-03-31 28
2011-12-31 29
2011-09-30 29
2011-06-30 29
2011-03-31 29
2010-12-31 29
2010-09-30 29
2010-06-30 29
2010-03-31 29
2009-12-31 29
2009-09-30 29
2009-06-30 29
2009-03-31 29
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.156B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $70.359B 18.83
Becton Dickinson (BDX) United States $67.554B 19.62
West Pharmaceutical Services (WST) United States $28.238B 47.74
Cardinal Health (CAH) United States $25.184B 15.14
Align Technology (ALGN) United States $23.613B 45.61
Cooper (COO) United States $17.928B 27.13
Labcorp (LH) United States $17.493B 14.94
Henry Schein (HSIC) United States $9.406B 16.27
DENTSPLY SIRONA (XRAY) United States $6.412B 16.90
Merit Medical Systems (MMSI) United States $4.299B 24.59
Patterson (PDCO) United States $2.346B 11.24
STAAR Surgical (STAA) United States $2.337B 73.57
Atrion (ATRI) United States $0.747B 38.46
Lifevantage (LFVN) United States $0.079B 12.85
Pro-Dex (PDEX) United States $0.065B 24.67
Biolase (BIOL) United States $0.005B 0.00